Valuation: China Resources Pharmaceutical Group Limited

Market Cap 27.27B 3.47B 3.1B 2.89B 2.63B 4.95B 336B 5B 34.75B 13.59B 171B 13.04B 12.76B 550B P/E 2026 *
5.57x
P/E 2027 * 5.22x
Enterprise Value 76.5B 9.75B 8.7B 8.12B 7.38B 13.88B 944B 14.02B 97.49B 38.13B 480B 36.6B 35.8B 1,543B EV / Sales 2026 *
0.23x
EV / Sales 2027 * 0.2x
Free-Float
29.17%
Yield 2026 *
4.69%
Yield 2027 * 5.07%
1 day-0.12%
1 week+0.93%
Current month-2.58%
1 month-2.91%
3 months-2.36%
6 months-31.19%
Current year-2.58%
1 week 4.22
Extreme 4.225
4.38
1 month 4.22
Extreme 4.225
4.47
Current year 4.22
Extreme 4.22
6.53
1 year 4.22
Extreme 4.22
6.53
3 years 4.22
Extreme 4.22
7.11
5 years 3.18
Extreme 3.18
8.13
10 years 3.18
Extreme 3.18
13.16
Manager TitleAgeSince
President 47 26/08/2025
Director of Finance/CFO 54 13/06/2023
Corporate Secretary - 15/12/2025
Director TitleAgeSince
Director/Board Member 59 01/06/2016
Director/Board Member 70 20/06/2016
Chairman 55 29/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
1/4/20 Other

Chief Executive Officer

200,000 0.0032%
31/3/20 Other

Chief Executive Officer

100,000 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%+0.93%-12.78%-13.82% 3.43B
-1.61%+1.72%+38.30%+106.93% 1,060B
-0.76%-0.84%+35.21%+62.70% 623B
+0.39%+4.81%+17.81%+83.77% 480B
-0.29%-0.99%+64.79%+37.06% 352B
-2.03%+1.06%+21.08%+42.16% 345B
-1.92%-0.29%+10.54%+33.20% 274B
-2.36%-1.16%-7.14%+8.68% 249B
-1.37%+0.04%+38.29%+52.33% 223B
+0.17%-0.27%+24.40%+96.82% 182B
Average -0.97%+0.06%+23.05%+50.98% 379.14B
Weighted average by Cap. -1.05%+0.73%+30.38%+68.75%

Financials

2026 *2027 *
Net sales 328B 41.77B 37.3B 34.8B 31.61B 59.48B 4,045B 60.06B 418B 163B 2,056B 157B 153B 6,611B 341B 43.42B 38.77B 36.17B 32.86B 61.83B 4,205B 62.43B 434B 170B 2,137B 163B 159B 6,872B
Net income 4.82B 615M 549M 512M 465M 875M 59.53B 884M 6.15B 2.4B 30.25B 2.31B 2.26B 97.28B 5.18B 660M 589M 550M 499M 940M 63.9B 949M 6.6B 2.58B 32.47B 2.48B 2.42B 104B
Net Debt 49.24B 6.27B 5.6B 5.23B 4.75B 8.93B 608B 9.02B 62.74B 24.54B 309B 23.55B 23.04B 993B 42.53B 5.42B 4.84B 4.51B 4.1B 7.72B 525B 7.79B 54.2B 21.2B 267B 20.35B 19.9B 858B
Projected Income Statement - Annual - China Resources Pharmaceutical Group Limited
Logo China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Ltd is an investment holding company principally engaged in the pharmaceutical business. The Company operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.
Employees
84,000
Date Price Change Volume
09/10/26 HKD 4.370 +0.69% 2,578,500
08/10/26 HKD 4.340 +1.17% 6,699,984
07/10/26 HKD 4.290 -0.69% 4,335,280
06/10/26 HKD 4.320 +0.35% 1,261,118
05/10/26 HKD 4.305 +0.23% 3,273,000
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - China Resources Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
4.340HKD
Average target price
6.489HKD
Spread / Average Target
+49.52%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - China Resources Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 3320 Stock